Man Group
SGMO

Man Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Man Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,185
Closed -$10.4K – 2345
2024
Q4 		$10.4K Buy
+10,185
New +$18.6K ﹤0.01% 1958
2023
Q3 		– Sell
-157,850
Closed -$169K – 1849
2023
Q2 		$205K Buy
+157,850
New +$216K ﹤0.01% 1817
2023
Q1 		– Sell
-144,740
Closed -$413K – 1832
2022
Q4 		$454K Buy
144,740
+104,801
+262% +$407K ﹤0.01% 1537
2022
Q3 		$196K Buy
+39,939
New +$205K ﹤0.01% 1779
2021
Q1 		– Sell
-135,166
Closed -$2.11M – 1979
2020
Q4 		$2.11M Sell
135,166
-19,283
-12% -$226K 0.01% 1184
2020
Q3 		$1.46M Buy
154,449
+23,310
+18% +$252K 0.01% 1287
2020
Q2 		$1.18M Buy
131,139
+75,190
+134% +$698K 0.01% 1231
2020
Q1 		$356K Buy
55,949
+17,000
+44% +$126K ﹤0.01% 1352
2019
Q4 		$326K Hold
38,949
– – ﹤0.01% 1658
2019
Q3 		$352K Sell
38,949
-69,849
-64% -$784K ﹤0.01% 1638
2019
Q2 		$1.17M Buy
108,798
+6,000
+6% +$63.8K ﹤0.01% 1479
2019
Q1 		$981K Buy
102,798
+33,520
+48% +$342K ﹤0.01% 1586
2018
Q4 		$795K Sell
69,278
-73,974
-52% -$919K ﹤0.01% 1523
2018
Q3 		$2.43M Buy
143,252
+160
+0.1% +$2.43K 0.01% 1341
2018
Q2 		$2.03M Buy
143,092
+85,900
+150% +$1.43M 0.01% 1354
2018
Q1 		$1.09M Buy
+57,192
New +$1.22M 0.01% 1490

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Man Group's SGMO Position: Q1 2025 in Review

Man Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 10,185 shares — an estimated $10.4K sold.

Man Group first reported a position in SGMO in Q1 2018 and held it in 16 quarters. The position peaked at $2.43M in Q3 2018. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Man Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Man Group sold 10,185 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $10.4K.
  • Man Group first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 16 quarters.
  • Man Group's SANGAMO THERAPEUTICS INC position peaked at $2.43M in Q3 2018.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Man Group's 13F filing for Q1 2025, filed 15 May 2025.